| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/15/2011 | CN101422454B Omega-3 polyunsaturated fatty acid tanshinone IIA sub-microemulsion and preparation method thereof |
| 06/15/2011 | CN101416990B Jasmine flower extract and preparation method and use thereof |
| 06/15/2011 | CN101416989B Extraction method of antihypertensive active substance in red rice and red rice antihypertensive medicine |
| 06/15/2011 | CN101385819B Medicine for treating the hemorrhoids and preparation method thereof |
| 06/15/2011 | CN101381366B Benzimidazole derivative and its use as a ii receptor antagonist |
| 06/15/2011 | CN101176788B Pharmaceutical composition for ACE restrainer/uretica/folic acid, and uses thereof |
| 06/15/2011 | CN101130515B Substituted-1H- indoles compound, method for preparing the same, application and pharmaceutical composition of the same |
| 06/15/2011 | CN101119718B Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics |
| 06/15/2011 | CN101072778B Novel pyrrolo [3, 2-d] pyrimidin-4-one derivatives and their use in therapy |
| 06/15/2011 | CN101062130B Yang recuperating decoction soft capsule preparing method |
| 06/15/2011 | CN101044120B Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same |
| 06/15/2011 | CN101028341B Magnoliaceae plant extract, its production and use |
| 06/15/2011 | CN100998651B Medicine for treating thromboembolia type disease and its preparing method |
| 06/14/2011 | USRE42462 Carboxylic acid derivatives, their preparation and use |
| 06/14/2011 | USRE42461 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 06/14/2011 | US7960579 2-amino-bicyclo [3.1.0] hexane-2,6-dicarboxylic ester derivative |
| 06/14/2011 | US7960433 Treatment of chemokine mediated diseases |
| 06/14/2011 | US7960416 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization |
| 06/14/2011 | US7960412 Selective estrogen receptor modulator |
| 06/14/2011 | US7960411 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 06/14/2011 | US7960395 5,7-disubstituted thiazolo[4,5-d]pyrimidines for the selective inhibition of chemokine receptors |
| 06/14/2011 | US7960394 3,8-dimethyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]-4(3H)-quinazolinone; 6-chloro-3-methyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]pyrido[3,4-d]-pyrimidin-4(3H)-one; 2-[4-(1-cyclopentyl-4-piperidinyloxy)phenyl]-3-methylpyrido[2,3-d]-pyrimidin-4(3H)-one; treats metabolic, nervous system, vascular disorders |
| 06/14/2011 | US7960375 new 8-chloro-2,3-benzodiazepine derivatives of the general formula (I), wherein R stands for a lower alkyl group or a group of the general formula NH R', wherein R' stands for a lower alkyl or a lower cycloalkyl group), and pharmaceutically acceptable acid addition salts thereof for intermediates. |
| 06/14/2011 | US7960369 Receptor function regulator |
| 06/14/2011 | US7959947 Film coating |
| 06/14/2011 | US7959945 Bosentan; excipients, filler, lubricant, disintegrant, acidifying agent, flavouring, sweetening; endothelin receptor inhibitor; pulmonary arterial hypertension |
| 06/14/2011 | CA2556489C Use of folates for the prevention and treatment of vascular diseases |
| 06/14/2011 | CA2496676C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 06/14/2011 | CA2480987C Natural products and derivatives thereof for protection against neurodegenerative diseases |
| 06/14/2011 | CA2480678C New heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 06/14/2011 | CA2468704C Urea derivatives as angiogenesis inhibitors |
| 06/14/2011 | CA2452752C Dye-azide compounds for dual phototherapy |
| 06/14/2011 | CA2452738C Gastric retention controlled drug delivery system |
| 06/14/2011 | CA2451859C Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain |
| 06/14/2011 | CA2445322C Use of the abc expression promoting agent pioglitazone for the treatment of arteriosclerosis obliterans |
| 06/14/2011 | CA2443325C Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 06/14/2011 | CA2437966C 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical |
| 06/14/2011 | CA2436421C Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same |
| 06/14/2011 | CA2433667C Prodrugs of excitatory amino acids |
| 06/14/2011 | CA2430669C Synthesis of 3-amino-thalidomide and its enantiomers |
| 06/14/2011 | CA2428468C New 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them |
| 06/14/2011 | CA2426292C Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression |
| 06/14/2011 | CA2425311C Ketone compounds and compositions for cholesterol management and related uses |
| 06/14/2011 | CA2293829C Methods and compositions for galactosylated glycoproteins |
| 06/14/2011 | CA2200540C Use of l-carnitine or derivatives thereof and antioxidants for the prevention and treatment of diseases elicited by oxidative stress to the nervous and cardiovascular system |
| 06/09/2011 | WO2011069046A1 Composition and methods for the prevention and treatment of macular degeneration, diabetic retinopathy, and diabetic macular edema |
| 06/09/2011 | WO2011069038A2 Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| 06/09/2011 | WO2011068211A1 2-pyridone compounds |
| 06/09/2011 | WO2011068171A1 Bicyclic nitrogen-containing saturated heterocyclic derivatives |
| 06/09/2011 | WO2011067983A1 Adipocyte sheet, three-dimensional structure thereof, and method for producing the same |
| 06/09/2011 | WO2011067560A1 Combination of droloxifene and clopidogrel |
| 06/09/2011 | WO2011067403A1 Starch derivative mixtures |
| 06/09/2011 | WO2011067366A1 Indazole derivatives as pi 3 - kinase inhibitors |
| 06/09/2011 | WO2011009851A3 Walnut extracts for nutraceutical applications |
| 06/09/2011 | WO2010057036A3 Solid composition for controlled release of ionizable active agents with poor aqueous solubility at low ph and methods of use thereof |
| 06/09/2011 | WO2010013144A8 Antihypertensive composition containing an extract of hymenocardia acida |
| 06/09/2011 | US20110136917 Tetrahydro-isoalpha acid compositions and methods for weight management |
| 06/09/2011 | US20110136914 Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity |
| 06/09/2011 | US20110136911 Treatment of sepsis and inhibition of mif by d-t4 |
| 06/09/2011 | US20110136906 Use of hydroxyoleic acid and related compounds in the manufacture of drugs |
| 06/09/2011 | US20110136905 Crystalline teglicar |
| 06/09/2011 | US20110136899 Combination of dronedarone with at least one diuretic, and therapeutic use thereof |
| 06/09/2011 | US20110136894 Shortened Alk1 Regulatory Fragment |
| 06/09/2011 | US20110136890 Treatment of fibrotic conditions |
| 06/09/2011 | US20110136889 Compositions and their uses directed to aceytl-coa carboxylases |
| 06/09/2011 | US20110136888 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof |
| 06/09/2011 | US20110136884 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 06/09/2011 | US20110136883 Granulation of active pharmaceutical ingredients |
| 06/09/2011 | US20110136881 Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents |
| 06/09/2011 | US20110136879 Compound |
| 06/09/2011 | US20110136871 2-alkoxy-substituted dicyanopyridines and their use |
| 06/09/2011 | US20110136869 Compounds Which Selectively Modulate The CB2 Receptor |
| 06/09/2011 | US20110136861 Quinolone inhibitors of lipoprotein-associated phospholipase a2 |
| 06/09/2011 | US20110136860 Compounds |
| 06/09/2011 | US20110136857 Pyrrole[2,3-b]pyridine derivatives active as kinase inhibitors |
| 06/09/2011 | US20110136856 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 06/09/2011 | US20110136853 Ligand with a broad spectrum of pharmacological activity, a pharmaceutical composition, a medicinal agent and a method of treatment |
| 06/09/2011 | US20110136833 Tetrahydropyridinyl and Dihydropyrrolyl Compounds and the Use Thereof |
| 06/09/2011 | US20110136830 Chromenone derivatives |
| 06/09/2011 | US20110136827 Bis-Acylated Hydroxylamine Derivatives |
| 06/09/2011 | US20110136825 Treatment of Vasomotor Symptoms |
| 06/09/2011 | US20110136824 Urotensin ii receptor antagonists |
| 06/09/2011 | US20110136818 Therapeutic compositions containing macitentan |
| 06/09/2011 | US20110136815 Solid oral film dosage forms and methods for making same |
| 06/09/2011 | US20110136808 3',6-substituted indirubins and their biological applications |
| 06/09/2011 | US20110136807 Bicyclic compositions and methods for modulating a kinase cascade |
| 06/09/2011 | US20110136793 Ameliorating drug-induced elevations in blood pressure by adjunctive use of antihypertensive drugs |
| 06/09/2011 | US20110136790 Tricyclic Heterocyclic Derivatives and Methods of Use |
| 06/09/2011 | US20110136789 C-met protein kinase inhibitors |
| 06/09/2011 | US20110136783 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists |
| 06/09/2011 | US20110136779 Methods for stroke reduction in atrial fibrillation patients |
| 06/09/2011 | US20110136760 Kinase Inhibitors Useful for the Treatment of Myleoproliferative Diseases and other Proliferative Diseases |
| 06/09/2011 | US20110136757 Hypersulfated disaccharide formulations |
| 06/09/2011 | US20110136746 Kallikrein-Binding "Kunitz Domain" Proteins and Analogues Thereof |
| 06/09/2011 | US20110136739 Use of S1P Receptor Agonists in Heart Diseases |
| 06/09/2011 | US20110136737 DPP-IV Resistant GIP Hybrid Polypeptides with Selectable Properties |
| 06/09/2011 | US20110136735 Cyclohexane derivatives and uses thereof |
| 06/09/2011 | US20110136733 Analogues of glucose-dependent insulinotropic polypeptide |
| 06/09/2011 | US20110136725 Analogues of glucose-dependent insulinotropic polypeptide (gip) modified at n-terminal |
| 06/09/2011 | US20110136724 Analogues of glucose-dependent insulinotropic polypeptide |